ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Healy Saw Scripps Issue as Way To Revisit Conflict Of Interest

March 19, 1993

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

October 24, 1986

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982